Literature DB >> 22575212

Use of recreational drug 1,3 Dimethylamylamine (DMAA) [corrected] associated with cerebral hemorrhage.

Paul Gee1, Cheryl Tallon, Neil Long, Grant Moore, Ronald Boet, Suzanne Jackson.   

Abstract

Dimethylamylamine (DMAA) was a forgotten pharmaceutical that was patented in 1944 as a nasal decongestant. DMAA has recently gained popularity as a dietary supplement, with claims of effectiveness as an athletic performance enhancer and weight loss aid. It is also sold as a recreational stimulant drug. DMAA is a sympathomimetic and potent pressor agent. This report describes 3 cases of cerebral hemorrhage in adults after the use of DMAA. The status of this substance as a synthetic or naturally occurring compound is also discussed.
Copyright © 2012. Published by Mosby, Inc.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22575212     DOI： 10.1016/j.annemergmed.2012.04.008

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN： 0196-0644            Impact factor:   5.721


  9 in total

1.  Abuse liability of the dietary supplement dimethylamylamine.

Authors:  Sean B Dolan; Michael B Gatch
Journal:  Drug Alcohol Depend       Date:  2014-11-25       Impact factor: 4.492

2.  The Role of Adverse Event Reporting in the FDA Response to a Multistate Outbreak of Liver Disease Associated with a Dietary Supplement.

Authors:  Karl C Klontz; Heidi J DeBeck; Pamela LeBlanc; Kathryn M Mogen; Beverly J Wolpert; Jonathan L Sabo; Monique Salter; Sharon L Seelman; Susan E Lance; Caitlin Monahan; David S Steigman; Kathleen Gensheimer
Journal:  Public Health Rep       Date:  2015 Sep-Oct       Impact factor: 2.792

Review 3.  Adverse Effects of Nutraceuticals and Dietary Supplements.

Authors:  Martin J J Ronis; Kim B Pedersen; James Watt
Journal:  Annu Rev Pharmacol Toxicol       Date:  2017-10-06       Impact factor: 13.820

4.  Effects of controlled doses of Oxyelite Pro on physical performance in rats.

Authors:  Paulo Vinicios Camuzi Zovico; Victor Magalhães Curty; Marcos André Soares Leal; Eduardo Frizzera Meira; Daniel Ventura Dias; Lívia Carla de Melo Rodrigues; Silvana Dos Santos Meyrelles; Edilamar Menezes De Oliveira; Paula Frizera Vassallo; Valério Garrone Barauna
Journal:  Nutr Metab (Lond)       Date:  2016-12-06       Impact factor: 4.169

5.  Boost Me: Prevalence and Reasons for the Use of Stimulant Containing Pre Workout Supplements Among Fitness Studio Visitors in Mainz (Germany).

Authors:  Matthias Dreher; Tobias Ehlert; Perikles Simon; Elmo W I Neuberger
Journal:  Front Psychol       Date:  2018-07-17

Review 6.  Analytical Challenges and Metrological Approaches to Ensuring Dietary Supplement Quality: International Perspectives.

Authors:  Alessandra Durazzo; Barbara C Sorkin; Massimo Lucarini; Pavel A Gusev; Adam J Kuszak; Cindy Crawford; Courtney Boyd; Patricia A Deuster; Leila G Saldanha; Bill J Gurley; Pamela R Pehrsson; James M Harnly; Aida Turrini; Karen W Andrews; Andrea T Lindsey; Michael Heinrich; Johanna T Dwyer
Journal:  Front Pharmacol       Date:  2022-01-11       Impact factor: 5.810

7.  Disparities and guideline adherence in drugs of abuse screening in intracerebral hemorrhage.

Authors:  Laura M Tormoehlen; Ashley D Blatsioris; Elizabeth A S Moser; Ravan J L Carter; Alec Stevenson; Susan Ofner; Abigail L Hulin; Darren P O'Neill; Aaron A Cohen-Gadol; Thomas J Leipzig; Linda S Williams; Jason Mackey
Journal:  Neurology       Date:  2016-12-07       Impact factor: 9.910

8.  Physiological and pharmacokinetic effects of oral 1,3-dimethylamylamine administration in men.

Authors:  Brian K Schilling; Kelley G Hammond; Richard J Bloomer; Chaela S Presley; Charles R Yates
Journal:  BMC Pharmacol Toxicol       Date:  2013-10-04       Impact factor: 2.483

9.  Surveillance of the armed forces as a sentinel system for detecting adverse effects of dietary supplements in the general population.

Authors:  Harris R Lieberman; Krista G Austin; Emily K Farina
Journal:  Public Health Nutr       Date:  2017-11-20       Impact factor: 4.022
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.